Antifungal prophylaxis in hematopoietic stem cell transplant recipients

Keyphrases

• Empirical Therapy 100%
• Antifungal Prophylaxis 100%
• Hematopoietic Stem Cell Transplant Recipients 100%
• Prophylactic Treatment 50%
• Less Toxic 50%
• Aspergillus 50%
• Amphotericin B 50%
• Active Agent 50%
• Potential Toxicity 50%
• Candidiasis 50%
• Fluconazole 50%
• Treatment Algorithm 50%
• Fungal Infection 50%
• Polyenes 50%
• Broad-spectrum Agents 50%
• Microbiological Diagnosis 50%
• Risk Periods 50%
• Underlying Risk 50%
• Multiple Alternatives 50%
• Allogeneic Hematopoietic Stem Cell Transplant Recipients 50%
• Anticandida 50%
• Diflucan 50%
• Anti-Candida Activity 50%
• Polyene Antifungal 50%

Immunology and Microbiology

• Hematopoietic Stem Cell Transplantation 100%
• Mould 100%
• Infectious Agent 50%
• Infectious Disease 50%
• Infection 50%
• Empirical evidence 50%
• Aspergillus 25%
• Candida 25%

Pharmacology, Toxicology and Pharmaceutical Science

• Mould 100%
• Infectious Agent 50%
• Fluconazole 50%
• Polyene 50%
• Infection 25%
• Aspergillus 25%
• Amphotericin B 25%
• Mycosis 25%
• Candida 25%
• Candidiasis 25%